(Q52667064)

5 May 2018

title

Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. (English)

1 reference

5 May 2018

0 references

Spino M

1

1 reference

5 May 2018

Chai RP

2

1 reference

5 May 2018

Isles AF

3

1 reference

5 May 2018

Balfe JW

4

1 reference

5 May 2018

Brown RG

5

1 reference

5 May 2018

Thiessen JJ

6

1 reference

5 May 2018

MacLeod SM

7

1 reference

5 May 2018

language of work or name

English

0 references

publication date

1 July 1985

1 reference

5 May 2018

The Journal of Pediatrics

published in

1 reference

5 May 2018

volume

107

1 reference

5 May 2018

issue

1

1 reference

5 May 2018

page(s)

64-70

1 reference

5 May 2018

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Aminoglycoside clearance in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Pharmacokinetics of tobramycin in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Theophylline disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Cloxacillin absorption and disposition in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Renal clearance investigations with 51 Cr-EDTA and 125 I-hippuran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

A program package for simulation and parameter estimation in pharmacokinetic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Technetium-99m DTPA: A New Radiopharmaceutical for Brain and Kidney Scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Diurnal variations of renal function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Effects of environmental heat stress and exercise on renal blood flow and filtration rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Renal function in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Renal function in cystic fibrosis with special reference to the renal sodium handling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Renal function in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Gentamicin Levels in the Human Biliary Tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

In vivo penetration of antibiotics into sputum in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Ceftazidime disposition in acute and stable cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Iatrogenic hyperuricemia in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Relationship of urate and p-aminohippurate secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980616-8

10.1016/S0022-3476(85)80616-8

7 January 2021

Identifiers

DOI

1 reference

5 May 2018

PubMed ID

3891948

1 reference

5 May 2018